Gen-Probe to Acquire Prodesse for at Least $60M | GenomeWeb

NEW YORK (GenomeWeb News) – Gen-Probe said after the close of the market Tuesday that it has signed a definitive agreement to acquire Prodesse for at least $60 million in cash.

Gen-Probe said that the acquisition price for the privately held molecular diagnostics firm could rise to up to $85 million if certain financial and regulatory milestones are met in 2010 and 2011.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: molecular surveillance of S. Typhi, genome-wide association study of attention in children, and more.

Clinicians look to fold non-medical data into algorithms to predict patients' health, the Wall Street Journal reports.

Connecticut's biotech investment is leading to the building of labs to house new startups, the Associated Press reports.

Craig Venter's Health Nucleus aims to change preventive medicine, according to the Robb Report.